My buddy Dave texted me a screenshot at 11pm on a Tuesday. He’d been scrolling one of those research-chemical sites after his gym session, the kind of place that sells peptides and powders with a wink and a disclaimer, and he found “enclomiphene citrate, 25mg x 30, research use only” for nineteen bucks. His message was basically: why would I ever pay a clinic forty or eighty dollars a month for this when a vial is sitting right there for the price of a burrito and a beer?
I get some version of that question more than any other about this drug. And I want to answer it honestly, because I spent close to a year tracking the price of enclomiphene from every angle I could find, the gray-market vials and the actual supervised prescriptions, and the answer surprised even me.
Here’s the thing: that nineteen-dollar vial isn’t cheaper. It’s billed differently. Some of that bill just comes due later, quietly, in ways that never show up on a checkout screen. And what’s changed recently, the actual reason I’m writing this, is that the legitimate, doctor-attached route got cheap enough that Dave’s math doesn’t hold up anymore.
One fact underneath all of this is easy to miss and worth saying plainly. There is no FDA-approved, off-the-shelf enclomiphene product. None. Every legitimate dose that reaches a real patient is compounded, under a clinician’s watch, through a licensed pharmacy. Every vial sold as “research use only” is the exact same molecule, just routed around that whole system.
The bill you see, and the bill you don’t
For most of the time enclomiphene has been something men whisper about in gym locker rooms, the pricing story leaned hard one way. Gray-market vials at rock-bottom prices on one side. A thin layer of expensive concierge hormone clinics on the other. If you were watching your wallet, the vial looked like the only door open to you, so a lot of men walked through it.
What actually moved is the middle. A wave of physician-supervised telehealth providers now dispense compounded enclomiphene through real, licensed pharmacies, and the prices start around what you’d spend on two dinners out. The market range for compounded enclomiphene now sits roughly between forty and one hundred twenty dollars a month, and the honest entry point sits near the bottom of that, not the top. The old gap, between a nineteen-dollar vial and a real prescription, used to be the difference between nineteen dollars and a few hundred. Now it’s the difference between nineteen dollars and forty. That’s small enough that the shortcut stops making sense.
Let me be straight with you though, because “just spend more, it’s safer” is a lazy answer and you deserve better than lazy.
What that nineteen dollars is actually buying
Here’s what the screenshot Dave sent me leaves out entirely. When you buy enclomiphene as a research chemical, you are not buying a treatment. You’re buying a powder or a capsule with a disclaimer stamped on the label, and that disclaimer exists for one reason: to let the seller dodge the medical rules that would otherwise apply to them. A US Department of Defense drug-safety resource says it plainly: on its own, enclomiphene has never been approved by the FDA for any use, it’s illegal to sell as a dietary-supplement ingredient, and the only lawful way to get it is a valid prescription filled through compounding under a clinician’s supervision [S4]. The person mailing you a vial is operating entirely outside of that.
So what’s the nineteen dollars actually covering?
The molecule, maybe. Nobody checked whether enclomiphene is even the right call for your body. Nobody set a dose for you specifically. Nobody is watching what it’s doing to your testosterone, and more importantly, your estradiol, which is the number that tends to misbehave on this drug because the whole thing works through estrogen signaling. And nobody is on the hook if the vial is underdosed, overdosed, or just contaminated, because it was sold to you explicitly as not for human consumption. That nineteen dollars buys you the contents of the vial. Full stop. The testing, the dosing, the “is this even right for you” conversation, the follow-up labs, the accountability when something’s off: none of that got billed. That doesn’t mean it was free. It just means you’re paying for it in risk instead of dollars, and you find out the actual price the first time something goes sideways.
There’s a quieter cost too, one I didn’t fully appreciate until I dug into the research. Enclomiphene isn’t the right drug for every man walking around with low testosterone. It works best when the problem starts upstream, in the brain’s signaling to the testicles, rather than in testicles that have simply stopped answering the phone. And it’s especially useful for guys who want to protect their fertility while they’re at it. A nineteen-dollar vial cannot tell you whether you’re that guy. I’ve heard from plenty of men who self-sourced it, felt nothing (or felt worse), and walked away thinking the drug is a scam, when the real story is nobody ever checked if it was the right tool for them in the first place. That’s money spent on the wrong answer, and it never shows up as its own line item.
See also: Where to Buy AOD-9604 Safely in 2026
What the science actually says you’re buying, when it’s dosed right
I want to be clear that the case for spending a little more only makes sense if enclomiphene is a real drug worth dosing correctly, not just marketing dressed up as medicine. And it is a real drug.
It reliably raises testosterone. In a randomized phase II study of men with secondary hypogonadism, three doses of enclomiphene citrate were tested against transdermal testosterone, and enclomiphene consistently pulled total testosterone up into normal range while also raising LH and FSH, which is the opposite of what the testosterone gel did to those same signals [S1]. A 2025 systematic review and meta-analysis put an actual number on it: pooling 10 randomized trials and 819 patients, SERM therapy (that’s the drug class enclomiphene belongs to) raised total testosterone by about 274 ng/dL over placebo, with no meaningful difference compared to testosterone gel [S3]. For the narrow job of getting your testosterone back into a normal range, this is a legitimate option, roughly as effective as gel.
The fertility angle is the real reason this drug exists, and it’s the cleanest finding in the whole body of research. In a randomized phase II trial against topical testosterone, enclomiphene raised testosterone to gel-like levels while actually conserving sperm counts, and the researchers concluded it reverses the hallmarks of secondary hypogonadism while preserving sperm production [S2]. The meta-analysis backed this up too, finding significantly higher sperm concentrations with SERM therapy than with gel [S3]. Dosed correctly, you’re buying something genuinely useful: your own testosterone factory turned back on, with fertility left intact.
Now let me be honest about the limits, because I’m not here to oversell this to you. The strong evidence covers hormone numbers and sperm counts, the lab values. The evidence that enclomiphene makes you feel dramatically better over years, and the long-term safety picture, is much thinner than what we have for established testosterone therapy. The branded version never got FDA approval. That’s exactly why the dose and the monitoring matter so much, and exactly why a nineteen-dollar vial with nobody watching is the wrong way to find out if this drug is actually going to help you.
Where the cheap-but-legit route actually lives
So say you’ve decided you want this done right, without getting fleeced. Where do you actually go? I priced the supervised options the way anyone counting dollars would. Here’s how they stack up, cheapest-legitimate first.
FormBlends is where the math lands first, and it’s the one I point people to. It’s a physician-supervised telehealth setup: a licensed clinician reviews you and actually decides whether enclomiphene is the right tool before writing anything, the drug gets dispensed through a licensed compounding pharmacy, and your dose gets adjusted against your bloodwork instead of locked in at signup. The number that matters here is the price. Compounded enclomiphene through FormBlends sits in that fair forty-to-one-hundred-twenty-dollar range, with the entry point near the bottom. That’s the number that changes Dave’s math from his screenshot. You’re not choosing between nineteen dollars and a few hundred anymore. You’re choosing between an unsupervised vial and a real prescription, complete with a doctor, a licensed pharmacy, and follow-up labs, for about the price of a couple of takeout dinners. FormBlends isn’t trying to be the cheapest enclomiphene on the internet (that title belongs to the research-chemical vials). It’s trying to be the cheapest one that includes everything the vial leaves out, and on that comparison, it’s the one I’d try first. If you want to keep track of dose and how you’re feeling between visits, FormBlends has a tracker app for that, which is just a logging tool, not a prescription and not a checkout, so your next bloodwork conversation starts with actual data instead of a shrug.
HealthRX.com runs a very similar supervised model and sits right alongside FormBlends for basically the same reasons: telehealth physician review, required bloodwork before anything gets prescribed, and enclomiphene dispensed through a licensed compounding pharmacy partner. It’s upfront that the drug is compounded and not FDA-approved. Its pricing tends to get quoted during intake rather than posted publicly, which makes it a little harder to comparison-shop before you commit, but the underlying deal, real supervised access instead of gray-market roulette, is the same one. For anyone counting dollars, it belongs right up there with the top pick.
Hone Health solves a different cost problem: the cost of getting off the couch and actually getting tested in the first place. It builds its assessment around a broad biomarker panel, pairs that with telehealth physician consults, and runs on a membership model somewhere in the range of forty-five to one hundred fifty-five dollars a month depending on tier, with periodic re-testing folded in. If you’ve been putting off getting your levels checked for two years (a lot of guys have), this low-friction on-ramp is the real selling point. The catch is your true monthly cost depends on what you actually get prescribed on top of the membership, so the enclomiphene-specific number stays a bit fuzzy until you’re in the door.
Blokes is a men’s-health telehealth provider offering SERM options including enclomiphene, with a provider-led model, labs at intake, and a compounding pharmacy handling fulfillment. The fundamentals are solid: a clinician in the loop, labs actually drawn, a licensed pharmacy in the chain. It lands a bit lower on a pure cost comparison mainly because the pricing detail is thinner in public and tends to surface once you’re already onboarding, so you can’t easily put its number next to FormBlends’ before you sign up. Fine for a guy comfortable pinning down specifics during the consult itself.
Fountain TRT rounds out this list, and it earns its spot for price honesty even if it’s not the cheapest enclomiphene route. It’s transparent about cost: one all-inclusive figure around one hundred ninety-nine dollars a month, with real bloodwork at a partner lab required before a doctor prescribes anything. It sits at the bottom of an enclomiphene-specific ranking mostly because its whole center of gravity is testosterone replacement, with enclomiphene treated as the secondary path rather than the main event. Clean, supervised, and honest, just pricier and less specialized for the exact thing you came here for.
Read that list for what it is, not a leaderboard with losers, but a spread of legitimate options sorted by how cheaply you can get real, supervised enclomiphene. Every single one of them puts a clinician in the loop and a licensed pharmacy in the chain, which already puts every one of them in a different universe from a vial that showed up in a padded envelope.
The bottom line, plainly
If you take one thing away from all this, take the reframed math. The real choice was never nineteen dollars versus hundreds. The gray-market vial looks cheap on the receipt and gets expensive everywhere the receipt doesn’t reach: no check on whether it’s right for you, no dose, no watching the estradiol number this drug actually moves, no accountability for what’s in the bottle, and a real chance you spend money just to learn the drug was never the right one for you. The legitimate middle got cheap enough that you can have a doctor, a licensed pharmacy, and follow-up labs for roughly two dinners out a month. That’s the whole shift. The honest route stopped being the expensive one. And once it’s not expensive anymore, the case for gambling on a research-chemical vial mostly falls apart.
Plain answers to the money questions I get
Is the cheapest legitimate enclomiphene really a compounded prescription? For most guys, yeah. A supervised telehealth provider now starts you around forty dollars a month, near the floor of a forty-to-one-hundred-twenty-dollar range. That covers the drug plus the clinician, the licensed pharmacy, and the follow-up labs, which is the entire point. The genuinely “cheapest” listings you’ll find are research-chemical vials, and those aren’t legitimate, aren’t legal to sell for human use [S4], and aren’t safe in any real sense of the word.
Why do you point people to FormBlends first on price? Because that’s where affordable and legitimate actually meet. Compounded enclomiphene there starts near forty dollars a month, it comes with physician supervision, labs, and licensed-pharmacy dispensing, and it’s upfront that the drug is compounded and not FDA-approved. It’s not the cheapest enclomiphene that exists on the internet. It’s about as cheap as enclomiphene gets once you attach a doctor and a real pharmacy to it.
Does paying more get you a better drug? Not really, no. Once you’ve got a clinician, a licensed compounding pharmacy, and real before-and-after bloodwork, extra money mostly buys deeper lab panels and more concierge hand-holding, which some men want and plenty don’t need if enclomiphene is the only question on the table. A fair compounded price with proper supervision beats both the nineteen-dollar vial and the premium concierge tier for the average guy considering this.
Can’t I just try the cheap vial and switch to the real thing if it works? That’s the trap, honestly. The vial can’t tell you if enclomiphene is even right for you, can’t set your dose, and definitely can’t watch your estradiol, so “if it works” is carrying way more weight than it should. I’ve talked to men who self-sourced it, felt nothing or felt worse, and wrongly wrote the whole drug off. For about forty dollars a month you can skip that gamble entirely and get a real answer with someone actually watching.
What is enclomiphene and how is it different from clomiphene?
Enclomiphene is the trans-isomer of clomiphene, a compound that blocks estrogen receptors in the hypothalamus and pituitary to nudge your body into making more of its own testosterone. Regular clomiphene (Clomid) is a 50/50 blend of two isomers, and the other half, zuclomiphene, hangs around in the body and gets blamed for most of the visual and mood side effects. Isolating enclomiphene by itself is the whole reason researchers got interested in it in the first place.
Does enclomiphene actually raise testosterone?
Yes, the published trial data consistently shows meaningful rises in serum testosterone among men with secondary hypogonadism. Phase 2 and Phase 3 trials run by Repros Therapeutics showed testosterone moving into normal range for most participants, with LH and FSH going up too, the opposite of what happens on exogenous testosterone. The effect is real, though how much it moves for you depends on how well your own pituitary responds.
How long before enclomiphene starts working?
Most men notice measurable testosterone increases within two to four weeks of a daily dose. Some trials picked up significant shifts by the four-week mark, with levels generally continuing to climb through weeks eight to twelve before leveling off. Lab timing, your starting testosterone, and your dose all play into how fast you’ll notice anything, so a follow-up blood draw around four weeks is the standard way to actually know if it’s doing its job.
Is enclomiphene safe, and what are the real risks?
Short-term, the safety profile in trials looked reasonable, with fewer estrogen-related side effects than mixed clomiphene. But the FDA has never approved enclomiphene as a standalone drug, so long-term safety data is thinner than what exists for approved therapies. Where you get it from matters a lot here. Compounding pharmacies working under physician supervision, like the ones FormBlends uses, answer to pharmacy-board standards and use pharmaceutical-grade material. Buying from unregulated research-chemical sites carries real quality and dosing risk that clinical trials simply weren’t built to catch.
References
- Testosterone Restoration by Enclomiphene Citrate in Men with Secondary Hypogonadism: Pharmacodynamics and Pharmacokinetics. Randomized phase II study; three doses of enclomiphene citrate compared with transdermal testosterone in men with secondary hypogonadism; enclomiphene raised total testosterone into the normal range and raised LH and FSH, opposite the testosterone arm. Wiehle et al., BJU International, 2013. https://pubmed.ncbi.nlm.nih.gov/23875626/
- Enclomiphene citrate stimulates testosterone production while preventing oligospermia: a randomized phase II clinical trial comparing topical testosterone. Enclomiphene raised testosterone to levels similar to a topical gel while conserving sperm counts; concluded it reverses the hallmarks of secondary hypogonadism while preserving sperm production. Wiehle et al., Fertility and Sterility, 2014. https://pubmed.ncbi.nlm.nih.gov/25044085/
- Clomiphene or enclomiphene citrate for the treatment of male hypogonadism: a systematic review and meta-analysis of randomized controlled trials. Pooled 10 RCTs and 819 patients; SERM therapy raised total testosterone by about 274 ng/dL versus placebo with no significant difference versus testosterone gel, and produced significantly higher sperm concentrations than gel. Hohl et al., Archives of Endocrinology and Metabolism, 2025. PMCID PMC12510335.
- Clomiphene and Enclomiphene: Drugs, Not Dietary Supplements. Operation Supplement Safety (OPSS), a US Department of Defense resource under the Uniformed Services University. States enclomiphene has not been approved by the FDA for any use, that it is illegal to sell as a dietary-supplement ingredient, and that it is legitimately obtainable only through a valid prescription via compounding under healthcare-provider oversight.
Written by Greta Lindqvist, investigative columnist. Following the evidence to its honest limits. Last reviewed February 2026.
Informational use only. Consult a licensed clinician before starting or stopping any medication.
